The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data
Open accessAbstract
Few population estimates of brain metastasis in the United States are available, prompting this study. Our objective was to estimate the expected number of metastatic brain tumors that would subsequently develop among incident cancer cases for 1 diagnosis year in the United States. Incidence proportions for primary cancer sites known to develop brain metastasis were applied to United States cancer incidence data for 2007 that were retrieved from accessible data sets through Centers for Disease Control and Prevention (CDC Wonder) and Surveillance, Epidemiology, and End Results (SEER) Program Web sites. Incidence proportions were identified for cancer sites, reflecting 80% of all cancers. It was conservatively estimated that almost 70 000 new brain metastases would occur over the remaining lifetime of individuals who received a diagnosis in 2007 of primary invasive cancer in the United States. That is, 6% of newly diagnosed cases of cancer during 2007 would be expected to develop brain metastasis as a progression of their original cancer diagnosis; the most frequent sites for metastases being lung and bronchus and breast cancers. The estimated numbers of brain metastasis will be expected to be higher among white individuals, female individuals, and older age groups. Changing patterns in the occurrence of primary cancers, trends in populations at risk, effectiveness of treatments on survival, and access to those treatments will influence the extent of brain tumor metastasis at the population level. These findings provide insight on the patterns of brain tumor metastasis and the future burden of this condition in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
(1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.594 · Cited by 1,929
Barnholtz-Sloan, J. S., Sloan, A. E., Davis, F. G., Vigneau, F. D., Lai, P., & Sawaya, R. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.149 · Cited by 1,843
Self-citationSchouten, L. J., Rutten, J., Huveneers, H. A. M., & Twijnstra, A. (2002) · Cancer · doi:10.1002/cncr.10541 · Cited by 1,590
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., Postmus, P., Collette, L., Musat, E., & Senan, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071780 · Cited by 1,133
Mead, G. M., Stenning, S. P., Cook, P. A., Fosså, S. D., Horwich, A., Kaye, S. B., Oliver, R. T. D., deMulder, P., deWit, R., Stoter, G., et al. (1997) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1,033
Brain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 975
Brain metastases: Histology, multiplicity, surgery, and survival
Nussbaum, E. S., Djalilian, H. R., Cho, K. H., & Hall, W. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961015)78:8<1781::aid-cncr19>3.0.co;2-u · Cited by 679
Pestalozzi, B. C., Zahrieh, D., Price, K. N., Holmberg, S. B., Lindtner, J., Collins, J., Crivellari, D., Fey, M. F., Murray, E., Pagani, O., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl064 · Cited by 413
Kalkanis, S. N., Kondziolka, D., Gaspar, L. E., Burri, S. H., Asher, A. L., Cobbs, C. S., Ammirati, M., Robinson, P. D., Andrews, D. W., Loeffler, J. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0061-8 · Cited by 412
Epidemiology of Metastatic Brain Tumors
Fox, B. D., Cheung, V. J., Patel, A. J., Suki, D., & Rao, G. (2011) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2010.08.007 · Cited by 317
(1989) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.39.1.3 · Cited by 313
Gore, E. M., Bae, K., Wong, S. J., Sun, A., Bonner, J. A., Schild, S. E., Gaspar, L. E., Bogart, J. A., Werner-Wasik, M., & Choy, H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.1609 · Cited by 308
Gaspar, L. E., Mehta, M. P., Patchell, R. A., Burri, S. H., Robinson, P. D., Morris, R. E., Ammirati, M., Andrews, D. W., Asher, A. L., Cobbs, C. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0060-9 · Cited by 299
Primary breast cancer phenotypes associated with propensity for central nervous system metastases
Tham, Y., Sexton, K., Kramer, R., Hilsenbeck, S., & Elledge, R. (2006) · Cancer · doi:10.1002/cncr.22041 · Cited by 232
Brain metastases admissions in Sweden between 1987 and 2006
Smedby, K. E., Brandt, L., Bäcklund, M. L., & Blomqvist, P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605373 · Cited by 229
Gastrointestinal cancer and brain metastasis: A rare and ominous sign
Go, P. H., Klaassen, Z., Meadows, M. C., & Chamberlain, R. S. (2011) · Cancer · doi:10.1002/cncr.25940 · Cited by 199
Survival among women with triple receptor-negative breast cancer and brain metastases
Dawood, S., Broglio, K., Esteva, F. J., Yang, W., Kau, S.-W., Islam, R., Albarracin, C., Yu, T. K., Green, M., Hortobagyi, G. N., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn682 · Cited by 165
Gaspar, L. E., Chansky, K., Albain, K. S., Vallieres, E., Rusch, V., Crowley, J. J., Livingston, R. B., & Gandara, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.026 · Cited by 165
Mongan, J. P., Fadul, C. E., Cole, B. F., Zaki, B. I., Suriawinata, A. A., Ripple, G. H., Tosteson, T. D., & Pipas, J. M. (2009) · Clinical Colorectal Cancer · doi:10.3816/ccc.2009.n.016 · Cited by 137
Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
Choi, H. J., Cho, B. C., Sohn, J., Shin, S. J., Kim, S. H., Kim, J. H., & Yoo, N. C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9713-3 · Cited by 116
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Massard, C., Zonierek, J., Gross‐Goupil, M., Fizazi, K. S., Szczylik, C. A., & Escudier, B. J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp411 · Cited by 103
Edelman, M. J., Belani, C. P., Socinski, M. A., Ansari, R., Obasaju, C. K., Chen, R., Monberg, M., & Treat, J. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c59a3a · Cited by 38
Cited by
Response assessment criteria for brain metastases: proposal from the RANO group
Lin, N. U., Lee, E. Q., Aoyama, H., Barani, I. J., Barboriak, D. P., Baumert, B. G., Bendszus, M., Brown, P. D., Camidge, D. R., Chang, S. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70057-4 · Cited by 1,088
Goldberg, S. B., Gettinger, S. N., Mahajan, A., Chiang, A. C., Herbst, R. S., Sznol, M., Tsiouris, A. J., Cohen, J., Vortmeyer, A., Jilaveanu, L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30053-5 · Cited by 993
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Vogelbaum, M. A., Brown, P. D., Messersmith, H., Brastianos, P. K., Burri, S., Cahill, D., Dunn, I. F., Gaspar, L. E., Gatson, N. T. N., Gondi, V., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02314 · Cited by 832
Soffietti, R., Abacioglu, U., Baumert, B., Combs, S. E., Kinhult, S., Kros, J. M., Marosi, C., Metellus, P., Radbruch, A., Villa Freixa, S. S., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now241 · Cited by 496
Brain metastases: epidemiology
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-811161-1.00002-5 · Cited by 336
Metadata
- Authors
- Davis, F. G., Dolecek, T. A., McCarthy, B. J., & Villano, J. L.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-09
- Volume
- 14
- Issue
- 9
- Pages
- 1171-1177
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2096557421
- Cited by
- 256
- References
- 23
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.